PharmaCorp names Andrew Hodson as CFO, replacing retiring Terri Tatchell

PharmaCorp Rx Inc. (TSXV: PCRX) announced that Andrew Hodson will join the company as Chief Financial Officer on October 27, 2026, succeeding Terri Tatchell, who will retire from the role on the same date.

Tatchell will remain with the Saskatoon, Saskatchewan-based company for three months as a consultant to assist with the transition of CFO responsibilities.

Hodson brings more than 11 years of financial leadership experience, including over six years leading global finance teams in high-growth and acquisition-driven businesses. Most recently, he served as Head of Finance for Marshall Land Systems Ltd., where he oversaw financial reporting across Canadian and UK entities.

Prior to that role, Hodson was VP Finance at Vendasta Technologies Inc., a Saskatoon-based software company, where he led finance workstreams for strategic acquisitions, including due diligence, valuation, transaction support and post-acquisition integration. He also supported capital markets initiatives at Vendasta, including prospectus development and shareholder communications.

Before Vendasta, Hodson spent six years at Deloitte Canada, where he led audit engagements for private and public companies in the technology and software-as-a-service sectors and advised clients on financial reporting, internal controls, and regulatory compliance.

Hodson holds a Master of Professional Accounting degree from the University of Saskatchewan and is a Chartered Professional Accountant.

PharmaCorp operates 17 PharmaChoice Canada-bannered pharmacies and describes itself as a Canadian pharmacy acquisition and ownership platform. The company's shares trade on the TSX Venture Exchange.

You May Also Be Interested In

• Robin Energy to acquire LPG carrier for $18M from CEO-linked entity
• Union Pacific (UNP) PT Raised to $328 at TD Cowen
• Bolt Biotherapeutics acquires Prana Therapies, raises $120M